Stroke, Acute Clinical Trial
Official title:
Telestroke in Nordland Hospital: Improved Treatment of Cerebral Stroke in Small Hospitals
The purpose is to study the clinical, technological and organizational impacts of a
telestroke service between Nordlandssykehuset, Bodø, and two small rural hospitals in Lofoten
and Vesterålen. The stroke specialist in Bodø will examine the patient in cooperation with
the doctor at the local hospital through video- and sound communication. Radiology images are
transmitted using the RIS/PACS system.
Telestroke consultations may be useful to assess whether the patient needs thrombolysis
medication, and also whether there is a need for more advanced specialist neurological or
neurosurgical treatment, supporting quick triaging and transfer to the appropriate unit.
The study design is a multi-method approach using before-and-after hospital information data
as well as registration forms monitoring patient outcome and pathways. The research questions
will be approached from medical, organisational and technological perspectives.
A telestroke service in North Norway is expected to face other challenges than those reported
internationally: In Nordlandssykehuset, as in Helse Nord in general, the number of cases is
low, clinicians have high turnover, technical support is not available 24/7 and severe
weather conditions and long distances might add to the transport time.
Primary hypothesis: The use of telestroke leads to faster and more accurate diagnosis and
proper treatment
Secondary hypothesis: Telestroke leads to improved overall patient treatment
There is good evidence that the prognosis for patients with ischemic stroke is improved by
thrombolysis in the acute phase. The challenge is the narrow time window: Thrombolysis should
be given as soon as possible and not later than 4.5 hours after the first symptoms. In
Norway, only approximately 2% of all stroke patients receive thrombolysis whereas 20 % are
expected to benefit from such treatment (The Norwegian Directorate of Health, 2010). The low
rate could be due to geographical conditions with long travel distances, lack of awareness in
the population, but also little experience with the treatment in local hospitals may play a
role.
The overall aim of this project is to improve health outcome for stroke patients by
telemedicine. This study will investigate the potential outcome for stroke patients in small
rural hospitals using a telestroke service.
The project will study the "patient flow‟ by analysing hospital information system (HIS) data
as well as monitoring the teleconsultations and logging the main purpose for and results of
the consultation. This will be conducted throughout the project, and analysed for a period of
18 months. Hospital data on diagnosis, thrombolysis frequencies, stroke complications like
haemorrhage or stroke recidive, will be used in the analysis process.
Around 60 cases may potentially be included in the study during the 18 month observation
period, which can be compared with register data from patients before the study.
Control-groups have been considered, but found not ethical since the telestroke equipment is
already installed in the two hospitals.
Log information from the Norwegian Health Net on the use of videoconferencing will be used as
a basis for field observations and interviews and to verify the actual use of the system.
Corresponding with the logged data, semi-structured interviews will be conducted by making
follow-up phone calls to hospital staff after the telestroke incidents. Using a qualitative
approach, the number of follow-up calls will be decided in the process, adding up to app 20
cases. This method will be used to capture what happened in the concrete telestroke incident
from the first call to the hospital and throughout the process, while the details of the
session are still fresh. There will also be periods of fieldwork at all three hospitals. This
will include observations at the hospital wards and during concrete telestroke consultations.
Semi-structured focus groups interviews will be conducted with health personnel involved with
stroke-patients, including ambulance personnel, doctors and nurses, as well as technical
support. Fieldwork will take place early in the project phase, and then at intervals during
the project period. Fieldwork and follow-up phone interviews at different times in the
research period will capture potential changes in the stroke treatment over time.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05378035 -
DOAC in Chinese Patients With Atrial Fibrillation
|
||
Completed |
NCT03574038 -
Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke
|
N/A | |
Completed |
NCT03679637 -
Tablet-based Aphasia Therapy in the Acute Phase After Stroke
|
N/A | |
Completed |
NCT03633422 -
Evaluation of Stroke Patient Screening
|
||
Completed |
NCT04088578 -
VNS-supplemented Motor Retraining After Stroke
|
N/A | |
Not yet recruiting |
NCT05534360 -
Tenecteplase Treatment in Ischemic Stroke Registry
|
||
Withdrawn |
NCT04991038 -
Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients
|
N/A | |
Not yet recruiting |
NCT04105322 -
Effects of Kinesio Taping on Balance and Functional Performance in Stroke Patients
|
N/A | |
Withdrawn |
NCT05786170 -
ERILs Und SNILs Unter SOC
|
N/A | |
Recruiting |
NCT03132558 -
Contrast Induced Acute Kidney in Patients With Acute Stroke
|
N/A | |
Completed |
NCT02893631 -
Assessment of Hemostasis Disorders in rtPA-treated Patients Requiring Endovascular Treatment for Ischemic Stroke
|
||
Active, not recruiting |
NCT02274727 -
Biomarker Signature of Stroke Aetiology Study: The BIOSIGNAL-Study
|
||
Completed |
NCT02225730 -
Imaging Collaterals in Acute Stroke (iCAS)
|
||
Terminated |
NCT01705353 -
The Role of HMGB-1 in Chronic Stroke
|
N/A | |
Active, not recruiting |
NCT01581502 -
SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF)
|
N/A | |
Completed |
NCT01182818 -
Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease
|
N/A | |
Completed |
NCT00761982 -
Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment.
|
Phase 1/Phase 2 | |
Completed |
NCT00535197 -
Autologous Bone Marrow Stem Cells in Ischemic Stroke.
|
Phase 1/Phase 2 | |
Terminated |
NCT00132509 -
FRALYSE Trial: Comparison of the Classical Rt-PA Procedure With a Longer Procedure in Acute Ischemic Stroke
|
Phase 2 | |
Recruiting |
NCT05760326 -
Diagnostic and Prognostic Role of Clot Analysis in Stroke Patients
|